Multifunctional Methotrexate-Laden Nanotherapy Modulates the Joint-Brain Axis and Attenuates Associated Neuroinflammation in an Experimental Model of Rheumatoid Arthritis.
The application of M-WPG NMs is supported as a next-generation nanomedicine for comprehensive RA management, capable of controlling disease progression while offering protection against RA-induced cognitive dysfunction and addresses the often-overlooked neurological components of RA.